LH vs CRL — Key Metrics

Metric LH (LABCORP HOLDINGS INC) CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC)
Price370.78333.25
Market Cap30.11 Billion15.97 Billion
P/E (TTM)30.22311.45
P/B (Quarterly)3.3174.845
P/S (TTM)2.064.02
Net Profit Margin (TTM)6.91.0
Gross Margin (TTM)29.033.3
ROE (TTM)11.51.3
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

LABCORP HOLDINGS INC
vs
 
CHARLES RIVER LABORATORIES INTERNATIONAL INC
 
LABCORP HOLDINGS INC
vs
 
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Performance Comparison
AI Model Recommendation
LH · LABCORP HOLDINGS INC

Underperform

-32
UnderperformOutperform
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC

Greatly Underperform

-80
UnderperformOutperform
Recommendation Summary

Stock LH is projected to underperform the market, stock CRL is projected to greatly underperform the market. Upfront Recommendation: LH.

Financial Metrics
Prices delayed ~15 min
LH Metrics CRL
$370.78 Price $333.25
— Market Capitalization —
30.22 Price to Earnings Ratio 311.45
2.06 Price to Sales 4.02
23.4 Price to FCF Ratio 39.96
7.12 Price to Gross Profit 12.05
7.59 Price to Current Assets 10.4

LH vs CRL at a glance

Labcorp Holdings INC (LH) and Charles River Laboratories International INC (CRL) are both Diagnostics & Research companies in the Healthcare sector. LH is the larger, at $30.1 billion in market value against $16.0 billion for CRL, about 1.9 times the size.

On trailing-twelve-month figures, LH trades at 30.2 times trailing earnings and CRL at 311.4; net profit margins are 6.9% and 1.0%.

The Upfront Investment model currently rates LH Underperform and CRL Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.